Cancer nanomedicines were initially envisioned as magic bullets, travelling through the
circulation to target tumours while sparing healthy tissues the toxicity of classic …

Nanomedicines are extensively explored for cancer therapy. By delivering drug molecules
more efficiently to pathological sites and by attenuating their accumulation in healthy organs …

The majority of nanomedicines in (pre) clinical trials are based on established drugs, such
as doxorubicin and paclitaxel. Does that make sense? To some extent yes, because a lot of …

Nanomedicine is a rapidly emerging field that holds great promise for the treatment of
cancer. Nanomedicine has the potential to completely alter the way cancer is treated since it …

Cancer is one of the main causes of death worldwide. To date, and despite the advances in
conventional treatment options, therapy in cancer is still far from optimal due to the non …

Nanomedicine's application of nanotechnology in medicine holds tremendous potential for
diagnosing and treating life-threatening diseases such as cancer. Unlike conventional …

Glioblastoma (GBM) is a highly aggressive and lethal form of primary brain cancer.
Numerous barriers exist to the effective treatment of GBM including the tightly controlled …

The ability to efficiently deliver a drug or gene to a tumor site is dependent on a wide range
of factors including circulation time, interactions with the mononuclear phagocyte system …

Nanotechnology has the potential to increase the selectivity and potency of chemical,
physical, and biological approaches for eliciting cancer cell death while minimizing …

Cancer is a leading cause of death worldwide. Conventional chemotherapy has drawbacks
ranging from limited effectiveness, chemoresistance, and treatment-related side-effects and …